LANSING, Mich., Nov. 5, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2024 UBS Global Healthcare Conference in Rancho Palos Verdes, California, on Tuesday, November 12. About Neogen Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Li ...

Neogen Corporation (NEOG) reported first-quarter fiscal 2025 adjusted earnings per share (EPS) of 7 cents, down 36.4% from the prior-year quarter's registered numbers. The bottom line missed the Zacks Consensus Estimate by 30%. Revenues fell 5.2% on a year-over-year basis to $217 million. Core revenues declined 1.4%. Acquisitions and discontinued product lines did not impact core growth, while foreign currency had a negative impact of 3.9%. However, the metric surpassed the Zacks Consensus Estimate by 0.4%. ...

Shares of Neogen Corp. (NASDAQ: NEOG ) are down nearly 30% this year amid a string of disappointing results. The trend continued as the food science and animal safety diagnostic specialist reported its latest quarterly earnings, which came in below expectations. Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I ...

Neogen (NEOG) reported $216.96 million in revenue for the quarter ended August 2024, representing a yearover-year decline of 5.3%. EPS of $0.07 for the same period compares to $0.11 a year ago. The reported revenue represents a surprise of +0.39% over the Zacks Consensus Estimate of $216.11 million. With the consensus EPS estimate being $0.10, the EPS surprise was -30.00%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2024. or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17988 Neogen Corporation (Exact name of registrant as specified in its charter) Michigan 38-2367843 (State or other jurisdictio ...

Neogen Corporation (NASDAQ:NEOG) Q1 2025 Earnings Conference Call October 10, 2024 8:00 AM ET Company Participants Bill Waelke - Vice President, Investor Relations & Treasury John Adent - Chief Executive Officer Dave Naemura - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Brandon Vazquez - William Blair Thomas DeBourcy - Nephron Research Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation First Quarter 2025 Earnings Call. At this time, a ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------|-------|-------|------------------|---------------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | First | | Fiscal Year 2025 -Quarter | | | | | | | | | | | Results | | | | | | | | | | | | October 10, 2024 | | | Disclaimer Preliminary Results and Forward-Looking Statements The Company's reported results are preliminary. The Company has not yet completed it ...

Neogen (NEOG) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of -30%. A quarter ago, it was expected that this maker of medical testing kits would post earnings of $0.12 per share when it actually produced earnings of $0.10, delivering a surprise of -16.67%. Over the last four quarters, ...

Revenue of $217.0 million. Net loss of $12.6 million; $(0.06) per diluted share. Adjusted Net Income of $14.4 million; $0.07 per diluted share. Adjusted EBITDA of $43.7 million. Maintaining full-year guidance. LANSING, Mich., Oct. 10, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today the results of the first quarter ended August 31, 2024. "During the first quarter, the focus of our teams shifted from managing through the initial complexity of exiting the transition service agreements fr ...

Exhibit 99.1 Neogen Announces First-Quarter 2025 Results • Revenue of $217.0 million. • Net loss of $12.6 million; $(0.06) per diluted share. • Adjusted Net Income of $14.4 million; $0.07 per diluted share. • Adjusted EBITDA of $43.7 million. • Maintaining full-year guidance. LANSING, Mich., October 10, 2024 – Neogen Corporation (NASDAQ: NEOG) announced today the results of the first quarter ended August 31, 2024. "During the first quarter, the focus of our teams shifted from managing through the initial co ...